Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 361535, 7 pages
http://dx.doi.org/10.1100/2012/361535
Research Article

The Clinical COPD Questionnaire Correlated with BODE Index-A Cross-Sectional Study

1Division of Pulmonary & Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
2Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
3Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan

Received 14 November 2011; Accepted 15 January 2012

Academic Editor: Federico Varoli

Copyright © 2012 Shih-Feng Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Pauwels, A. S. Buist, P. M. Calverley, C. R. Jenkins, S. S. Hurd, and GOLD Scientific Committee, “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 5, pp. 1256–1276, 2001. View at Google Scholar
  2. B. R. Celli, C. G. Cote, J. M. Marin et al., “The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 350, no. 10, pp. 1005–1012, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Mahler, D. H. Weinberg, C. K. Wells, and A. R. Feinstein, “The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes,” Chest, vol. 85, no. 6, pp. 751–758, 1984. View at Google Scholar · View at Scopus
  4. P. S. Burge, P. M. Calverley, P. W. Jones, S. Spencer, J. A. Anderson, and T. K. Maslen, “Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial,” British Medical Journal, vol. 320, no. 7245, pp. 1297–1303, 2000. View at Google Scholar · View at Scopus
  5. K. Nishimura, T. Izumi, M. Tsukino, and T. Oga, “Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD,” Chest, vol. 121, no. 5, pp. 1434–1440, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Domingo-Salvany, R. Lamarca, M. Ferrer et al., “Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 5, pp. 680–685, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. K. C. Ong, A. Earnest, and S. J. Lu, “A multidimensional grading system (BODE index) as predictor of hospitalization for COPD,” Chest, vol. 128, no. 6, pp. 3810–3816, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. C. G. Cote and B. R. Celli, “Pulmonary rehabilitation and the BODE index in COPD,” European Respiratory Journal, vol. 26, no. 4, pp. 630–636, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. H. G. de Oliveira, A. V. Macedo-Neto, A. B. John et al., “Transbronchoscopic pulmonary emphysema treatment: 1-Month to 24-month endoscopic follow-up,” Chest, vol. 130, no. 1, pp. 190–199, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Imfeld, K. E. Block, W. Weder, and E. W. Russi, “The BODE index after lung volume reduction surgery correlates with survival,” Chest, vol. 129, no. 4, pp. 873–878, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. B. R. Celli, “Change in the BODE index reflects disease modification in COPD: lessons from lung volume reduction surgery,” Chest, vol. 129, no. 4, pp. 835–836, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Testa and D. C. Simonson, “Assessment of quality-of-life outcomes,” The New England Journal of Medicine, vol. 334, no. 13, pp. 835–840, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Schokker, B. W. Willemse, N. H. T. ten Hacken et al., “Responsiveness of the COPD control questionnaire (CCQ),” American Journal of Respiratory and Critical Care Medicine, vol. 165, article A833, 2002. View at Google Scholar
  14. S. Schokker, M. Everts, D. S. Postma et al., “Test-retest reliability of the COPD symptom control questionnaire,” American Journal of Respiratory and Critical Care Medicine, vol. 163, article A63, 2001. View at Google Scholar
  15. B. Willemse, D. S. Postma, T. van der Molen et al., “The COPD symptom control questionnaire (CSCQ) is associated with airways obstruction in smokers,” European Respiratory Journal, vol. 16, article 373s, 2000. View at Google Scholar
  16. T. van der Molen, E. F. Juniper, S. Schokker et al., “How can we measure COPD symptom control? The development of a COPD symptom control questionnaire,” American Journal of Respiratory and Critical Care Medicine, vol. 159, article A832, 1999. View at Google Scholar
  17. E. F. Juniper, G. H. Guyatt, and R. Jaeschke, “How to develop and validate a new quality of life instrument,” in Quality of Life and Pharmacoeconomics in Clinical Trials, B. Spilker, Ed., pp. 49–56, Raven Press, New York, NY, USA, 2nd edition, 1995. View at Google Scholar
  18. T. van der Molen, B. W. M. Willemse, S. Schokker, N. H. T. ten Hacken, D. S. Postma, and E. F. Juniper, “Development, validity and responsiveness of the clinical COPD questionnaire,” Health and Quality of Life Outcomes, vol. 1, article 13, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. A. Reda, D. Kotz, J. W. H. Kocks, G. Wesseling, and C. P. van Schayck, “Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire,” Respiratory Medicine, vol. 104, no. 11, pp. 1675–1682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. H. H. Kooi, M. G. Tuinenga, S. Schokker et al., “How to measure clinical control in patients with COPD: the development of the clinical COPD questionnaire (CCQ),” Quality of Life Newsletter, vol. 31, pp. 9–11, 2003. View at Google Scholar
  21. J. W. H. Kocks, M. G. Tuinenga, S. M. Uil, J. W. K. van den Berg, E. Stahl, and T. van der Molen, “Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire,” Respiratory Research, vol. 7, article 62, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. X. Lin, W. N. Xu, L. R. Liang et al., “The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease,” Chinese Medical Journal, vol. 122, no. 24, pp. 2939–2944, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Medinas Amorós, C. Mas-Tous, F. Renom-Sotorra, M. Rubi-Ponseti, M. J. Centeno-Flores, and M. T. Gorriz-Dolz, “Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index,” Chronic Respiratory Disease, vol. 6, no. 2, pp. 75–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Medinas-Amorós, C. Alorda, F. Renom et al., “Quality of life in patients with chronic obstructive pulmonary disease: the predictive validity of the BODE index,” Chronic Respiratory Disease, vol. 5, no. 1, pp. 7–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. The GOLD expert panel, “Global strategy for the diagnosis, management and prevention of COPD,” http://www.goldcopd.org/.
  26. D. A. Mahler and C. K. Wells, “Evaluation of clinical methods for rating dyspnea,” Chest, vol. 93, no. 3, pp. 580–586, 1988. View at Google Scholar · View at Scopus
  27. R. O. Crapo, R. Casaburi, A. L. Coates et al., “ATS statement: guidelines for the six-minute walk test,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 1, pp. 111–117, 2002. View at Google Scholar
  28. I. Rahman, D. Morrison, K. Donaldson, and W. Macnee, “Systemic oxidative stress in asthma, COPD, and smokers,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 4, pp. 1055–1060, 1996. View at Google Scholar · View at Scopus
  29. A. M. W. J. Schols, W. A. Buurman, A. J. Staal van den Brekel, M. A. Dentener, and E. F. M. Wouters, “Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease,” Thorax, vol. 51, no. 8, pp. 819–824, 1996. View at Google Scholar · View at Scopus
  30. J. Sauleda, F. Garcia-Palmer, R. J. Wiesner et al., “Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 5, pp. 1413–1417, 1998. View at Google Scholar · View at Scopus
  31. The American Thoracic Society and European Respiratory Society, “Skeletal muscle dysfunction in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 4, pp. S1–S40, 1999. View at Google Scholar · View at Scopus